PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF LESINURAD, A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN HEALTHY ADULT MALES

Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males

Zancong Shen, Colin Rowlings, Brad Kerr, Vijay Hingorani, Kimberly Manhard, Barry Quart, Li-Tain Yeh, Chris Storgard Ardea Biosciences, Inc.(a member of the AstraZeneca group), San Diego, CA, USA Abstract: Lesinurad is a selective uric acid reabsorption inhibitor under investigation for the treatment of gout.Single and multiple ascending dose studi

read more

APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage

Aim: The aim of this study was to assess the utility of weighted amide proton transfer (APTw) MRI in three different rodent models of hepatocellular carcinoma (HCC).Methods: APTw MRI was evaluated in models of diethylnitrosamine (DEN) induced HCC, N1S1 syngeneic orthotopic xenograft and human HepG2 ectopic xenograft.Results: All models of aireloom

read more


Understanding barriers and facilitators to clinic attendance and medication adherence among adults with hypertensive urgency in Tanzania.

Hypertensive urgency is a major risk factor for cardiovascular events and premature deaths.Lack of medication adherence is associated with poor health outcomes among patients with hypertensive urgency in resource-limited settings.To inform the development of tailored interventions to improve health outcomes in this population, this study aimed at u

read more